title: Production losses in Merino ewes and financial penalties caused by trichostrongylid infections during winter and spring.
abstract: The productivity of Merino ewes treated with ivermectin and a controlled-release capsule containing albendazole was compared with untreated ewes grazing the same pastures on each of 3 farms. Treated breeding ewes had significantly increased greasy fleece weights (GFW, 6.5% and 7.1%) compared with untreated breeding ewes, on 2 of 3 farms but treatment caused no significant increase in the GFW of non-breeding ewes. Other benefits of treatment on all farms were a significant increase in body weight gain (from 1.7 to 3.7 kg) and a significant decrease in the weight of dag removed at crutching (from 42 to 622 g). These benefits occurred despite the presence on each farm of worms resistant to benzimidazoles. One disadvantage of treatment was an increase in mean fibre diameter of wool from treated ewes of from 0.12 to 0.41 microns. This increase reduces the value of the wool. Partial budgets indicated a net loss of from 8 to 62 cents per ewe for treatment. However, potential benefits such as increased growth rate and wool production from lambs of treated ewes were not included in the analysis. On one farm ewes were classified as 'susceptible' to severe dag if they had a dag score > or = 4 at the time of capsule treatment. Ewes classified as 'susceptible' were about 7 times more likely to develop severe dag than were other ewes. There was no significant difference between the GFW of untreated 'susceptible' ewes and untreated ewes not classified as 'susceptible'.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Faculty of Veterinary Science, University of Melbourne, Werribee, Victoria.
authors.forename: J W
authors.initials: JW
authors.lastname: Larsen
authors.forename: A L
authors.initials: AL
authors.lastname: Vizard
authors.forename: N
authors.initials: N
authors.lastname: Anderson
mesh_terms: D015766:Albendazole / Q000191:economics / Q000627:therapeutic use*; D000818:Animals; D001835:Body Weight; D001947:Breeding / Q000191:economics; D003692:Delayed-Action Preparations; D005243:Feces / Q000469:parasitology; D005260:Female; D007559:Ivermectin / Q000191:economics / Q000627:therapeutic use*; D010270:Parasite Egg Count; D012621:Seasons; D012756:Sheep; D012757:Sheep Diseases / Q000191:economics* / Q000517:prevention & control; D014251:Trichostrongyloidea / Q000187:drug effects / Q000302:isolation & purification; D014252:Trichostrongyloidiasis / Q000191:economics / Q000517:prevention & control / Q000662:veterinary*; D015430:Weight Gain; D014935:Wool / Q000191:economics / Q000254:growth & development
chemical_list: D003692:Delayed-Action Preparations; D007559:Ivermectin; D015766:Albendazole